The receptor tyrosine kinase inhibitor vandetanib activates Akt and increases side population in a salivary gland tumor cell line (A253)
Keyword(s):
2020 ◽
Vol 44
(1)
◽
pp. 9-18
Keyword(s):
Keyword(s):
2021 ◽
Vol 45
(2)
◽
pp. 49-57
Keyword(s):
2017 ◽
Vol 41
(3)
◽
pp. 113-120
Keyword(s):
2020 ◽
2014 ◽
Vol 35
(8)
◽
pp. 915
2003 ◽
Vol 94
(5)
◽
pp. 453-458
◽
2021 ◽